Company Catalog
Build your portfolio here
Enter the quantity next to the stocks you need — your portfolio will be created automatically.
Quick screener: filter by category and recommendation, review fundamentals, metrics and company profiles.
How the catalog worksTotal stocks: 35
| Company | Category | Price | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Style | Horizon | Pot. | Risk | Recommendation | Portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Abivax (ABVX)
ext: ABVX
|
Biotech | 100.87 | +2.90% | 0.0% | 12.1% | -5.84 | -200.0% | 23.9% | Growth | Medium | 24 | 85 | Sell |
|
|
Alnylam Pharmaceuticals (ALNY)
ext: ALNY.US
|
Biotech | 289.39 | -0.63% | 0.0% | 2.1% | 4.36 | 6.4% | 73.2% | Growth | Medium | 42 | 69 | Sell |
|
|
Amgen (AMGN)
ext: AMGN.US
|
Biotech | 354.06 | +4.84% | 2.8% | 1.4% | 14.48 | -12.9% | 8.0% | Growth | Medium | 62 | 58 | Hold |
|
|
Arrowhead Pharmaceuticals (ARWR)
ext: ARWR.US
|
Biotech | 74.41 | +5.20% | 0.0% | 3.6% | -2.14 | -72.1% | 21.2% | Growth | Medium | 39 | 71 | Sell |
|
|
Atai Life Sciences (ATAI)
ext: ATAI.US
|
Biotech | 3.80 | +0.53% | 0.0% | 4.3% | -3.00 | -10.5% | 27.3% | Growth | Medium | 30 | 77 | Sell |
|
|
Bio-Techne (TECH)
ext: TECH.US
|
Biotech | 54.02 | +2.90% | 0.6% | 2.8% | 0.71 | 5.3% | -3.6% | Growth | Medium | 60 | 59 | Hold |
|
|
Biogen (BIIB)
ext: BIIB.US
|
Biotech | 199.96 | +2.94% | 0.0% | 2.1% | 9.37 | 8.7% | 17.0% | Growth | Medium | 69 | 45 | Buy |
|
|
Biohaven (BHVN)
ext: BHVN.US
|
Biotech | 11.37 | +2.71% | 0.0% | 5.8% | -5.67 | 0.0% | -2.3% | Growth | Medium | 48 | 70 | Hold |
|
|
BioNTech (BNTX)
ext: BNTX.US
|
Biotech | 89.54 | +3.93% | 0.0% | 1.9% | -5.09 | -86.6% | 3.7% | Growth | Medium | 30 | 77 | Sell |
|
|
Celcuity (CELC)
ext: CELC.US
|
Biotech | 89.49 | +1.42% | 0.0% | 6.7% | -3.89 | 0.0% | 9.3% | Growth | Medium | 24 | 85 | Sell |
|
|
Cidara Therapeutics (CDTX)
ext: CDTX.US
|
Biotech | 221.38 | 0.00% | 0.0% | 0.1% | -11.78 | 0.0% | 0.0% | Growth | Medium | 30 | 80 | Sell |
|
|
Corcept Therapeutics (CORT)
ext: CORT.US
|
Biotech | 83.25 | +6.57% | 0.0% | 3.7% | 0.45 | -18.4% | -111.3% | Growth | Medium | 69 | 64 | Hold |
|
|
Corvus Pharmaceuticals (CRVS)
ext: CRVS.US
|
Biotech | 11.60 | +3.94% | 0.0% | 4.7% | -0.55 | 0.0% | -7.1% | Growth | Medium | 30 | 71 | Sell |
|
|
Definium Therapeutics (DFTX)
ext: DFTX.US
|
Biotech | 24.11 | +3.74% | 0.0% | 3.6% | -2.50 | 0.0% | -44.3% | Growth | Medium | 57 | 73 | Hold |
|
|
Disc Medicine (IRON)
ext: IRON.US
|
Biotech | 68.08 | +1.23% | 0.0% | 3.0% | -6.64 | 0.0% | -1.7% | Growth | Medium | 30 | 75 | Sell |
|
|
Illumina Inc. (ILMN)
ext: ILMN.US
|
Biotech | 166.21 | +2.30% | 0.0% | 2.3% | 5.54 | -5.9% | 9.5% | Growth | Long | 64 | 60 | Hold |
|
|
ImmunityBio (IBIO)
ext: IBIO.US
|
Biotech | 1.67 | -1.76% | 0.0% | 5.4% | -0.58 | -100.0% | -16.7% | Growth | Medium | 20 | 80 | Sell |
|
|
Immunovant (IMVT)
ext: IMVT.US
|
Biotech | 32.88 | +5.45% | 0.0% | 8.4% | -2.78 | 0.0% | -21.7% | Growth | Medium | 41 | 69 | Sell |
|
|
Insilico Medicine (ISPC) (ISPC)
ext: ISPC
|
Biotech | 2.75 | +2.61% | 0.0% | 4.7% | -326.00 | 201.4% | 84.5% | Growth | Medium | 30 | 85 | Sell |
|
|
Insmed (INSM)
ext: INSM.US
|
Biotech | 96.72 | +5.27% | 0.0% | 6.1% | -5.75 | 16.0% | 15.6% | Growth | Medium | 24 | 85 | Sell |
|
|
Intellia Therapeutics (NTLA)
ext: NTLA.US
|
Biotech | 12.35 | +1.23% | 0.0% | 5.3% | -3.54 | -34.6% | 12.0% | Growth | Medium | 30 | 80 | Sell |
|
|
Neurocrine Biosciences (NBIX)
ext: NBIX.US
|
Biotech | 162.71 | +1.15% | 0.0% | 2.2% | 6.71 | 1.1% | 15.5% | Growth | Medium | 69 | 37 | Buy |
|
|
Ovid Therapeutics (OVID)
ext: OVID.US
|
Biotech | 2.21 | -3.07% | 0.0% | 3.7% | -0.35 | -100.0% | 0.0% | Growth | Medium | 30 | 80 | Sell |
|
|
Regeneron Pharmaceuticals (REGN)
ext: REGN.US
|
Biotech | 611.48 | +1.63% | 0.6% | 2.6% | 42.53 | -7.2% | 6.3% | Growth | Long | 33 | 74 | Sell |
|
|
Regenxbio (RGNX)
ext: RGNX.US
|
Biotech | 6.28 | +2.45% | 0.0% | 9.9% | -5.60 | -78.9% | -26.5% | Growth | Short | 14 | 90 | Sell |
|
|
Sarepta Therapeutics (SRPT)
ext: SRPT.US
|
Biotech | 15.00 | -0.73% | 0.0% | 3.4% | 0.62 | 65.0% | 223.8% | Growth | Medium | 24 | 85 | Sell |
|
|
Scholar Rock (SRRK)
ext: SRRK.US
|
Biotech | 44.69 | +1.36% | 0.0% | 2.9% | -3.45 | 0.0% | -1.2% | Growth | Medium | 30 | 70 | Sell |
|
|
Soleno Therapeutics (SLNO)
ext: SLNO.US
|
Biotech | 53.01 | 0.00% | 0.0% | 0.1% | 1.96 | 3.1% | -19.2% | Growth | Medium | 61 | 40 | Buy |
|
|
Terns Pharmaceuticals (TERN) (TERN)
ext: TERN.US
|
Biotech | 52.95 | 0.00% | 0.0% | 0.1% | -1.03 | 0.0% | 13.3% | Growth | Medium | 72 | 60 | Hold |
|
|
Ultragenyx Pharmaceutical (RARE)
ext: RARE.US
|
Biotech | 23.98 | +4.40% | 0.0% | 3.5% | -6.11 | -34.3% | -23.7% | Growth | Medium | 25 | 80 | Sell |
|